Jeena Sikho Lifecare (NSE:JSLL) Current Deferred Revenue: ₹0 Mil (As of Mar. 2026)


NSE:JSLL Jeena Sikho Lifecare Ltd NSE:JSLL
87 GF Score
Price ₹576.05
GF Value ₹775.57
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Jeena Sikho Lifecare Current Deferred Revenue?

Jeena Sikho Lifecare NSE:JSLL +0.29% 87 Current Deferred Revenue is ₹0 Mil as of Mar. 2026. GuruFocus rates NSE:JSLL with a GF Score™ of 87/100 and a GF Value™ of ₹775.57 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Jeena Sikho Lifecare's current deferred revenue for the quarter that ended in Mar. 2026 was ₹0 Mil.

Jeena Sikho Lifecare Current Deferred Revenue Related Terms

Jeena Sikho Lifecare Current Deferred Revenue Historical Data

* Premium members only.

The historical data trend for Jeena Sikho Lifecare's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jeena Sikho Lifecare Current Deferred Revenue Chart

Jeena Sikho Lifecare Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Current Deferred Revenue
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Jeena Sikho Lifecare Quarterly Data
Mar19 Mar20 Mar21 Sep21 Mar22 Mar23 Mar24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NSE:JSLL
87GF Score
Jeena Sikho Lifecare Ltd NSE:JSLL
Current Deferred Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Current Deferred Revenue of ₹0 Mil mean?
Jeena Sikho Lifecare (NSE:JSLL) has a Current Deferred Revenue of ₹0 Mil as of Mar. 2026. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Jeena Sikho Lifecare and its competitors.
Is Jeena Sikho Lifecare's Current Deferred Revenue too high?
Jeena Sikho Lifecare's current Current Deferred Revenue is ₹0 Mil. Overall, Jeena Sikho Lifecare has a GF Score™ of 87/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jeena Sikho Lifecare's Current Deferred Revenue compare to HCA and THC?
Jeena Sikho Lifecare's Current Deferred Revenue of ₹0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Deferred Revenue for a Healthcare Providers & Services company?
A good Current Deferred Revenue depends on the Healthcare Providers & Services industry context. However, Current Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Deferred Revenue mean?
A high Current Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Jeena Sikho Lifecare and its competitors. Jeena Sikho Lifecare's current Current Deferred Revenue is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jeena Sikho Lifecare stock overvalued right now?
Based on GuruFocus' analysis, Jeena Sikho Lifecare (NSE:JSLL) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹775.57, compared to a current price of ₹576.05 — trading 25.7% below its estimated fair value. The current Current Deferred Revenue is ₹0 Mil. Jeena Sikho Lifecare's overall GF Score™ is 87/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Deferred Revenue calculated?
Current Deferred Revenue is calculated from a company's financial statements. For Jeena Sikho Lifecare (NSE:JSLL), the current Current Deferred Revenue is ₹0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Jeena Sikho Lifecare (NSE:JSLL) Overvalued in 2026?

Based on GuruFocus' analysis, Jeena Sikho Lifecare stock appears to be undervalued. The current stock price of ₹576.05 is trading 25.7% below its estimated GF Value™ of ₹775.57. GuruFocus considers Jeena Sikho Lifecare to be Modestly Undervalued.

Key valuation signals for NSE:JSLL:

  • Current Deferred Revenue: ₹0 Mil
  • GF Value™: ₹775.57 vs. price of ₹576.05 (25.7% below fair value)
  • GF Score™: 87/100 with 3 warning signs

No single metric tells the full story. See the NSE:JSLL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Jeena Sikho Lifecare Business Description

Other Exchanges 544476:India
Address Kalgidhar Enclave, SCO 11 First Floor, Mohali, Zirakpur, PB, IND, 140604
Jeena Sikho Lifecare Ltd provides Ayurvedic healthcare products and services. The company operates only in one business segment which is Trading of Ayurvedic Medicines and providing Ayurvedic therapies. The company engages in conducting health check-up camps, and free yoga sessions to make people aware of health problems. It offers a wide range of Ayurvedic products such as Shuddhi 32 Herbs Tea, Shuddhi Addiction Free Kit, Shuddhi BP Package, Shuddhi Diabetes Care Package, and Shuddhi Divya Sanjeevani-Anti-Viral Package.
87GF Score

Get the complete analysis for NSE:JSLL

Current Deferred Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹576.05
Price
₹775.57
GF Value